Literature DB >> 8369656

Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.

K B Ain1, F Pucino, T M Shiver, S M Banks.   

Abstract

Patients receiving exogenous levothyroxine are reported to have higher total and free serum thyroxine levels than euthyroid controls. This may be an artifact of the serum collection time. We explored the effect of collection time on serum levels of thyroid hormones in outpatients receiving levothyroxine for replacement therapy (26 patients) or suppression of thyrotropin (25 patients). Blood samples, obtained during regular clinic visits (random samples) and at more than 22 h from ingestion of levothyroxine (trough samples), were assayed for total and free thyroxine, triiodothyronine, and thyrotropin. Four athyreotic patients on levothyroxine therapy had serial blood sampling over 24 h. Compared to corresponding trough samples, random samples had elevated total thyroxine levels in patients receiving replacement (8.1 +/- 1.2%, mean +/- SE, p = 0.0001) and in patients undergoing suppression (8.8 +/- 1.6%, p = 0.0001). Free thyroxine was increased by 12.7 +/- 2.6% (p = 0.0003) and 14.5 +/- 2.3% (p = 0.0001), respectively, compared with trough samples. Thyrotropin levels were 18.9 +/- 6.8% (p = 0.003) lower in patients receiving replacement and triiodothyronine levels showed small or no changes. Time-course analysis showed that free and total thyroxine levels remained significantly elevated above baseline for 9 and 5 h, respectively, after a levothyroxine dose. In conclusion, there is a transient increase in thyroid hormone levels for 9 h after an oral levothyroxine dose. Accurate assessment of thyroid hormone levels in patients receiving levothyroxine therapy should take this into account. This has greatest significance in selecting minimal levothyroxine dosages for suppression of thyrotropin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369656     DOI: 10.1089/thy.1993.3.81

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 2.  Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.

Authors:  Peter Laurberg; Stig Andersen; Inge Bülow Pedersen; Allan Carlé
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study.

Authors:  Offie P Soldin; Steven J Soldin; Alexander A Vinks; Islam Younis; Helain J Landy
Journal:  Ther Drug Monit       Date:  2010-12       Impact factor: 3.681

4.  Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.

Authors:  Jacqueline Jonklaas; Steven J Soldin
Journal:  Thyroid       Date:  2008-12       Impact factor: 6.568

5.  Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations.

Authors:  Jacqueline Jonklaas; Natasa Kahric-Janicic; Offie P Soldin; Steven J Soldin
Journal:  Clin Chem       Date:  2009-05-21       Impact factor: 8.327

6.  Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis.

Authors:  Maciej Owecki; Jolanta Dorszewska; Nadia Sawicka-Gutaj; Anna Oczkowska; Michał K Owecki; Michał Michalak; Jakub Fischbach; Wojciech Kozubski; Marek Ruchała
Journal:  BMC Endocr Disord       Date:  2014-03-01       Impact factor: 2.763

Review 7.  Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling.

Authors:  Nora Nikolac; Vesna Supak-Smolcić; Ana-Maria Simundić; Ivana Celap
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.